MetaADEDB 2.0 @ LMMD
Kanamycin
(SBUJHOSQTJFQJX-NOAMYHISSA-N)
Structure
SMILES
OC[C@H]1O[C@H](O[C@H]2[C@H](N)C[C@@H]([C@H]([C@@H]2O)O[C@H]2O[C@H](CN)[C@H]([C@@H]([C@H]2O)O)O)N)[C@@H]([C@H]([C@@H]1O)N)O
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
A07AA08; J01GB04; S01AA24
Molecular Formula:
C18H36N4O11
Molecular Weight:
484.499
Log P:
-4.4902
Hydrogen Bond Acceptor:
15
Hydrogen Bond Donor:
11
TPSA:
282.61
CAS Number(s):
59-01-8; 8063-07-8; 21558
Synonym(s)
1.
Kanamycin
2.
Kanamycin A
3.
Kanamycin Sulfate
4.
Kantrex
External Link(s)
MeSHD007612
PubChem Compound6032
BindingDB50031282
ChEBI17630
CHEMBLCHEMBL1384
DrugBankDB01172
DrugCentral1519
KEGGcpd:C01822
ZINC8214590
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1SyncopeFAERS: 2US FAERS
2DeafnessFAERS: 1

View details

CTD
OFFSIDES
SIDER
US FAERS
3Abdominal discomfortOFFSIDES
4Accidental overdoseOFFSIDES
5Acute kidney injury

View details

CTD
6AlbuminuriaSIDER
7Ammonia increasedOFFSIDES
8AmnesiaOFFSIDES
9AngerOFFSIDES
10AngioedemaCanada Vigilance: 1Canada Vigilance
11AnhedoniaOFFSIDES
12AnorexiaOFFSIDES
13AnxietyOFFSIDES
14ArteriosclerosisOFFSIDES
15ArthralgiaCanada Vigilance: 1Canada Vigilance
16AsbestosisOFFSIDES
17Atrioventricular BlockOFFSIDES
18Biliary sepsisOFFSIDES
19Blood albumin decreasedOFFSIDES
20Blood amylase increasedOFFSIDES
21Blood creatinine increasedCanada Vigilance: 1Canada Vigilance
22Blood pH decreasedOFFSIDES
23Blood urea increasedCanada Vigilance: 1Canada Vigilance
24Bone density decreasedOFFSIDES
25Bone painOFFSIDES
26Breakthrough PainOFFSIDES
27Breast prosthesis userOFFSIDES
28Bronchopleural FistulaOFFSIDES
29CellulitisOFFSIDES
30Cholecystitis infectiveOFFSIDES
31CirrhosisOFFSIDES
32Cochlear Diseases

View details

CTD
33Completed SuicideOFFSIDES
34ConfabulationOFFSIDES
35Cystitis1009330
2811228
CTD
36DEAFNESS, AMINOGLYCOSIDE-INDUCED23626763CTD
37DemyelinationOFFSIDES
38Denture wearerOFFSIDES
39Dermatitis, Allergic Contact18383004CTD
40DermatitisCanada Vigilance: 1Canada Vigilance
SIDER
41DiabetesOFFSIDES
42DizzinessOFFSIDES
43Drug withdrawal headacheOFFSIDES
44Ear Diseases

View details

CTD
45Enterococcal infectionOFFSIDES
46EpilepsyOFFSIDES
47Erythema MultiformeOFFSIDES
48ErythemaCanada Vigilance: 1Canada Vigilance
49Escherichia coli Infections1107297CTD
50Fetal Diseases7148437CTD
51General physical health deteriorationOFFSIDES
52HeadacheSIDER
53Hearing Loss, Bilateral8294265
12102302
CTD
54Hearing Loss, High-Frequency7148437CTD
55Hearing Loss

View details

CTD
56Heart-lung transplant rejectionOFFSIDES
57Hematuria2811228
4826627
CTD
58Hip surgeryOFFSIDES
59HypersensitivityCanada Vigilance: 1Canada Vigilance
60HypoxiaOFFSIDES
61Implant site effusionOFFSIDES
62Incision site infectionOFFSIDES
63Kidney Diseases

View details

CTD
64Kidney FailureOFFSIDES
65Klebsiella Infections1107297CTD
66Loose toothOFFSIDES
67LymphangitisOFFSIDES
68MalabsorptionSIDER
69Mallory-Weiss SyndromeOFFSIDES
70Meningitis1090107CTD
71Mental status changesOFFSIDES
72Metabolic acidosisOFFSIDES
73Muscle Weakness501488CTD
74NauseaSIDER
75Neisseriaceae Infections8335312CTD
76NystagmusSIDER
77Olfaction Disorders14676161CTD
78OliguriaSIDER
79Open reduction of fractureOFFSIDES
80OsteopeniaOFFSIDES
81OtotoxicitySIDER
82PainOFFSIDES
SIDER
83ParanoiaOFFSIDES
84Peripheral Nervous System Diseases6071516CTD
85Pleural decorticationOFFSIDES
86PolyuriaOFFSIDES
87Prenatal Exposure Delayed Effects6186586CTD
88Protein total decreasedOFFSIDES
89Proteinuria4826627CTD
90Proteus Infections1107297CTD
91PruritusCanada Vigilance: 1Canada Vigilance
92Rash erythematousCanada Vigilance: 2Canada Vigilance
93Reflex, Abnormal3835474CTD
94Respiratory FailureOFFSIDES
95Sepsis1090107CTD
96SeromaOFFSIDES
97Sinoatrial BlockOFFSIDES
98Tension HeadacheCanada Vigilance: 1Canada Vigilance
99ThrombophlebitisOFFSIDES
100Tinea PedisOFFSIDES
101TinnitusSIDER
102Tooth ExtractionOFFSIDES
103Tooth LossOFFSIDES
104Tuberculosis, Multidrug-Resistant18283911CTD
105Tuberculosis12102302CTD
106UrticariaCanada Vigilance: 1Canada Vigilance
107VertigoCanada Vigilance: 1Canada Vigilance
SIDER
108Vestibular toxicitySIDER
109VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.